Neuroscience and Cannabis
Implications for Law and Policy
- Watch the fully captioned event recording.
- Clea Simon, “Neuroscientist says jury still out on addictive qualities, effects on neurodevelopment of fetuses, adolescents,” The Harvard Gazette (April 20, 2022)
- Ryan H. Doan-Nguyen and Srija Vem, “Neuroscience and Law Experts Discuss Cannabis and Public Policy at Harvard Law School Panel,” The Harvard Crimson (April 21, 2022)
Event Description
The legalization of cannabis has raised significant questions for law and public policy. In this public event, neuroscientist Dr. Yasmin Hurd exploref the science of cannabis, CBD, and the future of substance use disorder treatment. Dr. Stephanie Tabashneck then moderated a discussion and audience Q&A about the implications for law and policy.
Panelists
- Introduction: Carmel Shachar, Executive Director, Petrie-Flom Center
- Yasmin Hurd, PhD, Ward-Coleman Chair, Translational Neuroscience, Professor Psychiatry and Neuroscience, and Director, Addiction Institute, Icahn School of Medicine at Mount Sinai
This event is part of the Project on Law and Applied Neuroscience, a collaboration between the Center for Law, Brain and Behavior at Massachusetts General Hospital and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School with support from the Oswald DeN. Cammann Fund at Harvard University.